Skip to contentB
BIO-TECHNE Corp
B
TECHBIO-TECHNE Corp Q3 2014 · 10-Q
Revenue$95.56M$95.56M+18.0% vs Q3 2013 Net Income$31.64M$31.64M−4.5% vs Q3 2013 EPS Diluted$0.85$0.85−5.6% vs Q3 2013 Gross Profit$68,111,000+11.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BIO-TECHNE Corp · CIK 842023 · Engraved from SEC EDGAR
Operating Cash Flowderived$34,934,000+5.8% Free Cash Flowderived$30,673,000+15.1% Margins · derivedGross margin71.3%−4.2 pt vs Q3 2013
Operating margin47.9%−6.4 pt vs Q3 2013
Net margin33.1%−7.8 pt vs Q3 2013
ended Mar 31, 2014 · filed May 12, 2014 · 42 d after period end